References
- SeamonLGRichardsonDLCopelandLJEvolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancerClin Obstet Gynecol201255113115522343234
- AACR-gynecological cancer: controlling recurrent ovarian cancerNat Rev Clin Oncol [Internet]2012 Available at http://www.nature.com/nrclinonc/journal/v9/n6/full/nrclinonc.2012.79.html
- ZhangYQTsaiYCMonieAWuTCHungCFEnhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapyMol Ther201018469269920087318
- UrbanskaKLanitisEPoussinMA universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptorCancer Res20127271844185222315351
- BennettSRCarboneFRKaramalisFFlavellRAMillerJFHeathWRHelp for cytotoxic-T-cell responses is mediated by CD40 signallingNature199839366844784809624004
- DiaconuICerulloVHirvinenMLImmune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirusCancer Res20127292327233822396493
- ZhangZMLiuJZhangFHInhibitory effects of enhanced expression of CD40L in ovarian cancer OVHM cells on the liver metastases in miceZhonghua Zhong Liu Za Zhi2009317505509 Chinese19950697
- ZhangZMZhangFHWangXMEnhanced expression of CD40L cDNA on ovarian cancer cell line OVHM induces the secretion of Th1 cytokines from dendritic cellsZhonghua Zhong Liu Za Zhi2008303174178 Chinese18756930
- OnaitisMWKaladyMFEmaniSAbdel-WahabZTylerDSPruittSKCD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapySurgery2003134230030512947333
- KatoKTakaueYWakasugiHT-cell-conditioned medium efficiently induces the maturation and function of human dendritic cellsJ Leukoc Biol200170694194911739557
- Mielczarek-PalaczASikoraJKondera-AnaszZHauzaGImbalance in serum soluble CD30/CD30 L and CD40/CD40L systems are associated with ovarian tumorsHum Immunol2013741707423073297
- AhmadzadehMRosenbergSATGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cellsJ Immunol200517495215522315843517
- YigitRFigdorCGZusterzeelPLPotsJMTorensmaRMassugerLFCytokine analysis as a tool to understand tumour-host interaction in ovarian cancerEur J Cancer201147121883188921514148
- HernandezMGShenLRockKLCD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell helpJ Immunol200717852844285217312128
- KaladyMFOnaitisMWEmaniSAbdel-WahabZTylerDSPruittSKSequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicityJ Sur Res200411612431
- BelladonnaMLRenauldJCBianchiRIL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cellsJ Immunol2002168115448545412023338
- MorishimaNOwakiTAsakawaMKamiyaSMizuguchiJYoshimotoTAugmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27J Immunol200517531686169316034109
- WatfordWTHissongBDBreamJHKannoYMuulLO’SheaJJSignaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4Immunol Rev200420213915615546391
- SchulzEGMarianiLRadbruchAHöferTSequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12Immunity200930567368319409816
- KimHJKimHOLeeKBaekEJKimHSTwo-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacityVaccine201028162877288620156531
- WanYYFlavellRARegulatory T cells, transforming growth factor-beta, and immune suppressionProc Am Thorac Soc20074327127617607012
- FengYHuaizengCXingXIn vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigenChin J Microbiol Immunol200424964967 Chinese